Moreover, repeated administration of PEGylated products may produce PEG antibodies, potentially reducing drug efficacy
First, the dose may not be high enough
Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide effect and action in diabetes (LEAD) trials
While there are stand-alone balancers on the market, I recommend purchasing a charger with built-in balancing capabilities, using a balance board like the one pictured to the right
How can I ask questions before completing the assessment
Krenn V, Morawietz L, Haupl T, Neidel J, Petersen I, Konig A